Insider Shareholders with Direct Ownership of Hcw Biologics Inc. (HCWB)
This section provides a comprehensive overview of the insiders with direct ownership of Hcw Biologics Inc. (HCWB). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
HCW Biologics Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Hing C Wong
Chief Executive Officer |
11,764,442 | 0 | 16,054,156 $6.58 Million | 18 |
Feb 20, 2024
Added 4.4%
|
|
Rebecca Byam
Chief Financial Officer |
1,354,909 | 0 | 1,381,909 $566,582 | 33 |
Feb 20, 2024
Added 35.5%
|
|
Lee Flowers
SVP of Business Development |
153,811 | 0 | 190,238 $77,997 | 8 |
Feb 20, 2024
Added 27.3%
|
|
Peter Rhode
Officer |
43,215 | 0 | 77,500 $31,774 | 4 |
Dec 11, 2023
Added 15.3%
|
|
Jin An Jiao
VP of Development |
24,570 | 0 | 45,141 $18,507 | 2 |
May 31, 2022
Added 3.66%
|
| 44,125 | 0 | 44,125 $18,091 | 3 |
Feb 20, 2024
Added 44.73%
|
|
| 35,715 | 0 | 35,815 $14,684 | 1 |
Feb 20, 2024
Added 49.93%
|
|
| 9,500 | 0 | 17,000 $6,970 | 14 |
Sep 14, 2023
Added 4.92%
|
|
|
Medmira Capital Ltd.
> 10% Shareholder |
3,587,661 | 3,587,659 | 0 $0 | 2 |
Sep 15, 2021
Reduced 100.0%
|